Hypomyelination with diffuse cerebral and cerebellar atrophy on magnetic resonance imaging (MRI), as well as the identification of the PLP1 gene mutation on whole exome sequencing, are pivotal in the early diagnosis of PMD to differentiate it from other neurodegenerative disorders [1]. The gene discussed is PLP1; the disease is Pelizeaus-Merzbacher spectrum disorder.